Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver
Gilead Sciences, Inc. (NASDAQ:GILD) is included among the 15 Best Boring Dividend Stocks to Buy. Gilead (GILD) Earns Buy Rating at Truist as HIV Franchise Continues to Deliver On November 24, Truist’s Gregory Renza initiated coverage of Gilead Sciences, Inc. (NASDAQ:GILD) with a Buy rating and set a price target of $140, slightly below the … Read more